The title compound, [Rh(C10H15)(C4H4N2)(C2H3N)2](PF6)2 or [CpRh(NCMe)2(N2C4H4)](PF6)2, where Cpis penta-methyl-cyclo-penta-dienyl, was obtained from the treatment of an acetonitrile solution of [CpRh(NCMe)3](PF6)2 with an excess of pyrimidine. The RhIII center is coordinated by one Cpring, two acetonitrile ligands and one pyrimidine ligand in a pseudo-octa-hedral geometry. Both PF6 anions are disordered (site occupancies ca 0.4:0.6, and 0.3:0.4:0.3).
|Original language||English (US)|
|Journal||Acta Crystallographica Section E: Structure Reports Online|
|State||Published - Oct 15 2007|
ASJC Scopus subject areas
- Materials Science(all)
- Condensed Matter Physics